J7198 Anti-inhibitor
Also known as: AICC, bypassing agent, Factor inhibitor bypass
Injection of anti-inhibitor coagulant complex, a prothrombin complex concentrate bypassing Factor inhibitors for hemostasis.
In Plain Language
clotting bypass medication; bleeding control
Clinical Context
Used for treatment of bleeding episodes in hemophilia A or B patients with Factor inhibitors, bypasses neutralizing antibodies.
RVU Information
CPT J7198 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J7198?
CPT J7198 (Anti-inhibitor) is a J Codes (Drugs) code. Injection of anti-inhibitor coagulant complex, a prothrombin complex concentrate bypassing Factor inhibitors for hemostasis.
How is J7198 administered?
CPT J7198 is administered by a healthcare provider, typically via injection or infusion. Used for treatment of bleeding episodes in hemophilia A or B patients with Factor inhibitors, bypasses neutralizing antibodies. It is used by Hematology, Hemophilia Specialty Clinic, Surgery.
When is CPT J7198 used?
Used for treatment of bleeding episodes in hemophilia A or B patients with Factor inhibitors, bypasses neutralizing antibodies.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.